Please ensure Javascript is enabled for purposes of website accessibility

West Bank Town Becomes ‘Big Prison’ as Israel Fences It In

3 days ago

Trump Says He’s Willing to Let Migrant Farm Laborers Stay in US

3 days ago

US Electric Vehicle Tax Breaks Will Expire on Sept. 30

4 days ago

Eyeing Arctic Dominance, Trump Bill Earmarks $8.6 Billion for US Coast Guard Icebreakers

4 days ago

Trump’s Sweeping Tax-Cut and Spending Bill Wins Congressional Approval

4 days ago

Americans Celebrate Their Independence With Record-Breaking Travel Numbers

4 days ago

US Supreme Court to Decide Legality of Transgender School Sports Bans

4 days ago

Nvidia Set to Become the World’s Most Valuable Company in History

4 days ago

Poll: 41% in US ‘Extremely Proud’ to Be American, Near Historic Low

4 days ago
Can Blood From Coronavirus Survivors Treat the Newly Ill?
gvw_ap_news
By Associated Press
Published 5 years ago on
March 25, 2020

Share

WASHINGTON — Hospitals are gearing up to test if a century-old treatment used to fight off flu and measles outbreaks in the days before vaccines, and tried more recently against SARS and Ebola, just might work for COVID-19, too: using blood donated from patients who’ve recovered.

“We won’t know until we do it, but the historical evidence is encouraging.” — Dr. Arturo Casadevall of Johns Hopkins University’s school of public health 
Doctors in China attempted the first COVID-19 treatments using what the history books call “convalescent serum” — today, known as donated plasma — from survivors of the new virus.
Now a network of U.S. hospitals is waiting on permission from the Food and Drug Administration to begin large studies of the infusions both as a possible treatment for the sick and as vaccine-like temporary protection for people at high risk of infection.
There’s no guarantee it will work.
“We won’t know until we do it, but the historical evidence is encouraging,” Dr. Arturo Casadevall of Johns Hopkins University’s school of public health told The Associated Press.
Casadevall drew on that history in filing the FDA application. The FDA is “working expeditiously to facilitate the development and availability of convalescent plasma” a spokesman said.
Here are some questions and answers about this latest quest for a treatment.

What Exactly Is This Possible Therapy?

It may sound like “back to the Stone Age,” but there’s good scientific reason to try using survivors’ blood, said Dr. Jeffrey Henderson of Washington University School of Medicine in St. Louis, who coauthored the FDA application with Casadevall and another colleague at the Mayo Clinic.
When a person gets infected by a particular germ, the body starts making specially designed proteins called antibodies to fight the infection. After the person recovers, those antibodies float in survivors’ blood — specifically plasma, the liquid part of blood — for months, even years.
One of the planned studies would test if giving infusions of survivors’ antibody-rich plasma to newly ill COVID-19 patients would boost their own body’s attempts to fight off the virus. To see if it works, researchers would measure if the treatment gave patients a better chance of living or reduced the need for breathing machines.
One caution: While regular plasma transfusions are a mainstay of medicine, very rarely they can cause a lung-damaging side effect.

Photo of a person receiving a vaccine
Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, Monday, March 16, 2020, at the Kaiser Permanente Washington Health Research Institute in Seattle. Browning is the second patient to receive the shot in the study. (AP Photo/Ted S. Warren)

Could It Also Act Like A Vaccine?

Sort of, but unlike a vaccine, any protection would only be temporary.

“We need both things desperately. We need to be able to break the cycle of transmission and we also need to be able to help people who are ill.” — Dr. Liise-anne Pirofski of New York’s Montefiore Health System and Albert Einstein College of Medicine
A vaccine trains people’s immune systems to make their own antibodies against a target germ. The plasma infusion approach would give people a temporary shot of someone else’s antibodies that are short-lived and require repeated doses.
Still, if FDA agrees, a second study would give antibody-rich plasma infusions to certain people at high risk from repeated exposures to COVID-19, such as hospital workers or first responders, said Dr. Liise-anne Pirofski of New York’s Montefiore Health System and Albert Einstein College of Medicine. That also might include nursing homes when a resident becomes ill, in hopes of giving the other people in the home some protection, she said.
“We need both things desperately,” Pirofski said. “We need to be able to break the cycle of transmission and we also need to be able to help people who are ill.”

What’s the History?

These plasma infusions were used most famously during the 1918 flu pandemic, and against numerous other infections, such as measles and bacterial pneumonia, before vaccines and modern medicines came along. Long-ago research is sketchy. But in the Journal of Clinical Investigation earlier this month, Casadevall and Pirofski cited evidence that 1918 flu patients given the infusions were less likely to die. And a 1935 medical report detailed how doctors stopped a measles outbreak from sweeping through a boarding school using “serum” from prior patients.
The old-fashioned approach still is dusted off every so often to tackle surprise outbreaks such as SARS in 2002, and in 2014 when Ebola survivors’ plasma was used to treat other patients during the West Africa epidemic. Even during those recent outbreaks, strict studies of the technique were not done, but Casadevall said there were clues that the plasma helped.
Casadevall thinks that when it didn’t work, it may have been used too late. “Somebody at the end of their lives, it’s very hard to affect” any disease at that point, he cautioned.
A more modern approach is to brew this type of antibody in the lab, something Regeneron Pharmaceuticals and other companies are working on. Using blood from COVID-19 survivors is a decidedly more labor-intensive approach — but researchers could start banking the plasma as soon as regulators give the OK.

How Would Doctors Get the Plasma?

Blood banks take plasma donations much like they take donations of whole blood; regular plasma is used in hospitals and emergency rooms every day. If someone’s donating only plasma, their blood is drawn through a tube, the plasma is separated and the rest infused back into the donor’s body. Then that plasma is tested and purified to be sure it doesn’t harbor any blood-borne viruses and is safe to use.

“I get multiple emails a day from people saying, ‘Can I help, can I give my plasma?’” — Dr. Liise-anne Pirofski 
For COVID-19 research, the difference would be who does the donating — people who have recovered from the coronavirus. Scientists would measure how many antibodies are in a unit of donated plasma — tests just now being developed that aren’t available to the general public — as they figure out what’s a good dose, and how often a survivor could donate.
Researchers aren’t worried about finding volunteer donors but caution it will take some time to build up a stock.
“I get multiple emails a day from people saying, ‘Can I help, can I give my plasma?’” Pirofski said.

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Netanyahu Nominates Trump for Nobel Peace Prize

DON'T MISS

Netanyahu Meets Trump at White House as Israel, Hamas Discuss Ceasefire

DON'T MISS

Trump Executive Order Seeks End to Wind and Solar Energy Subsidies

DON'T MISS

US Threatens California With Legal Action Over Transgender Sports Law

DON'T MISS

US Veterans Affairs Will Cut Nearly 30,000 Jobs, Far Fewer Than Planned

DON'T MISS

Houston Astros Donate $1M to Help Recovery From Texas Floods

DON'T MISS

Tucker Carlson Aired Interview With President of Iran

DON'T MISS

California Fails to Stop 23andMe Founder From Re-Acquiring Company

DON'T MISS

Madera County Multi-Agency Effort Leads to Arrest of Felony Suspect in Atwater

DON'T MISS

Fresno Police Arrest DUI Driver During Crackdown on Illegal Street Racing and Sideshows

UP NEXT

Netanyahu Meets Trump at White House as Israel, Hamas Discuss Ceasefire

UP NEXT

US Veterans Affairs Will Cut Nearly 30,000 Jobs, Far Fewer Than Planned

UP NEXT

Tucker Carlson Aired Interview With President of Iran

UP NEXT

US Proposes Rules That Could Boost Oil, Gas Output in US West

UP NEXT

Man Dead After Firing at US Border Patrol Station in Texas

UP NEXT

Israeli Guilt Over Gaza Lurks Beneath Silence and Denial

UP NEXT

Iran President Says Open to Dialogue With US, Accuses Israel of Assassination Attempt

UP NEXT

US-Backed 60-Day Gaza Ceasefire Envisages Gradual Return of Hostages, Official Says

UP NEXT

One Killed, Dozens Wounded in Russian Strikes on Kharkiv in Ukraine

UP NEXT

Texas Girls’ Camp Mourning Dozens Dead in Floods as Search Teams Face More Rain

US Threatens California With Legal Action Over Transgender Sports Law

2 hours ago

US Veterans Affairs Will Cut Nearly 30,000 Jobs, Far Fewer Than Planned

2 hours ago

Houston Astros Donate $1M to Help Recovery From Texas Floods

2 hours ago

Tucker Carlson Aired Interview With President of Iran

2 hours ago

California Fails to Stop 23andMe Founder From Re-Acquiring Company

3 hours ago

Madera County Multi-Agency Effort Leads to Arrest of Felony Suspect in Atwater

3 hours ago

Fresno Police Arrest DUI Driver During Crackdown on Illegal Street Racing and Sideshows

3 hours ago

July 4 Weekend Was No Picnic for Fresno-Area Firefighters. How Bad Did It Get?

4 hours ago

Tulare County Seizes 300 Pounds of Illegal Fireworks Over Fourth of July

4 hours ago

US Proposes Rules That Could Boost Oil, Gas Output in US West

5 hours ago

Netanyahu Nominates Trump for Nobel Peace Prize

WASHINGTON – Israeli Prime Minister Benjamin Netanyahu on Monday told President Donald Trump he had nominated him for the Nobel Peace ...

58 minutes ago

Israeli Prime Minister Benjamin Netanyahu looks on during a bilateral dinner with U.S. President Donald Trump (not pictured), at the White House in Washington, D.C., U.S., July 7, 2025. (Reuters/Kevin Lamarque)
58 minutes ago

Netanyahu Nominates Trump for Nobel Peace Prize

U.S. President Donald Trump meets with Israeli Prime Minister Benjamin Netanyahu at the White House in Washington, D.C., U.S., July 7, 2025. (Reuters/Kevin Lamarque)
1 hour ago

Netanyahu Meets Trump at White House as Israel, Hamas Discuss Ceasefire

A wind farm is shown in Movave, California, U.S., November 8, 2019. (Reuter File)
2 hours ago

Trump Executive Order Seeks End to Wind and Solar Energy Subsidies

U.S. Secretary of Education Linda McMahon testifies before a Senate Appropriations hearing on U.S. President Donald Trump's budget request for the Department of Education, on Capitol Hill in Washington, D.C., U.S., June 3, 2025. (Reuters File)
2 hours ago

US Threatens California With Legal Action Over Transgender Sports Law

United States Department of Veterans Affairs logo and U.S. flag are seen in this illustration taken April 23, 2025. (Reuters File)
2 hours ago

US Veterans Affairs Will Cut Nearly 30,000 Jobs, Far Fewer Than Planned

A group of search and rescue workers paddle a boat in the Guadalupe River in the aftermath of deadly flooding in Kerr County, Texas, U.S., July 7, 2025. (Reuters/Sergio Flores)
2 hours ago

Houston Astros Donate $1M to Help Recovery From Texas Floods

2 hours ago

Tucker Carlson Aired Interview With President of Iran

Attendees visit the 23andMe booth at the RootsTech annual genealogical event in Salt Lake City, Utah, U.S., February 28, 2019. (Reuters File)
3 hours ago

California Fails to Stop 23andMe Founder From Re-Acquiring Company

Help continue the work that gets you the news that matters most.

Search

Send this to a friend